AI-401 oral recombinant insulin: Phase II trial

AutoImmune Inc. (AIMM), Lexington,

Read the full 44 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE